Top FDA officials quit in anger over the white house and CDC overriding their authority over Covid booster shots and shots for children.

From DailyMail:

“Two of the U.S. Food and Drug Administration’s top vaccine regulators plan to leave the agency in the next several months amid a reported power struggle with the White House over COVID-19 booster shots. 

Dr. Marion Gruber, director of the FDA’s Office of Vaccines Research and Review, plans to step down on October 31 and her top deputy Dr. Philip Krause also plans to leave the FDA in November, according to a department memo seen by EndPoints News.”

From ArsTechnica:

“Two top vaccine regulators have resigned from the Food and Drug Administration, revealing anger, frustration, and turmoil at the federal agency as it faces intensifying pressure to authorize COVID-19 vaccine booster shots and doses for children under the age of 12.”

Politico, which spoke with 11 former and current health officials, described the situation at the FDA as a ‘potential mutiny’ among agency staff and outside vaccine experts.

Adding to the tension, the upheaval at the FDA comes as parents, caregivers, and teachers anxiously look to the agency to expeditiously review and authorize COVID-19 vaccine doses for young children, who are filling hospitals at higher rates than ever before during the pandemic.”

From EndPoints News:

“A former senior FDA leader told Endpoints that they’re departing because they’re frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA. The former FDAer also said he’s heard they’re upset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots.”

In a letter from Marks to staff, he explained: